These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6301706)

  • 1. Actions of opiate antagonists with selective receptor interactions in hemorrhagic shock.
    Curtis MT; Lefer AM
    Circ Shock; 1983; 10(2):131-45. PubMed ID: 6301706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of ethylketocyclazocine in hemorrhagic shock.
    Curtis MT; Lefer AM
    Adv Shock Res; 1983; 10():101-9. PubMed ID: 6308972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial action of a new opiate antagonist (Win 44,441-3) in hemorrhagic shock.
    Curtis MT; Lefer AM
    Eur J Pharmacol; 1982 Mar; 78(3):307-13. PubMed ID: 6279411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial actions of nalorphine during hemorrhagic shock in cats.
    Hock CE; Curtis MT; Jaffe JS; Lefer AM
    Proc Soc Exp Biol Med; 1983 May; 173(1):76-81. PubMed ID: 6304745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral effects of opiate antagonists in shock.
    Lefer AM; Curtis MT
    Adv Shock Res; 1983; 10():83-6. PubMed ID: 6308976
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of AVP in maintenance of circulatory homeostasis during hemorrhagic shock.
    Hock CE; Su JY; Lefer AM
    Am J Physiol; 1984 Feb; 246(2 Pt 2):H174-9. PubMed ID: 6696129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of cellular integrity as a protective mechanism of dexamethasone in hemorrhagic shock in the cat.
    Trachte GJ; Lefer AM
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):309-20. PubMed ID: 677964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone in endotoxic shock: experimental models and clinical perspective.
    Gurll N
    Adv Shock Res; 1983; 10():63-71. PubMed ID: 6308974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salutary effects of nitrendipine, a new calcium entry blocker, in hemorrhagic shock.
    Hock CE; Su JY; Lefer AM
    Eur J Pharmacol; 1984 Jan; 97(1-2):37-46. PubMed ID: 6698110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-shock actions of a new converting enzyme inhibitor, enalaprilic acid, in hemorrhagic shock in cats.
    Freeman JG; Hock CE; Edmonds JS; Lefer AM
    J Pharmacol Exp Ther; 1984 Dec; 231(3):610-5. PubMed ID: 6094795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an opiate antagonist (naloxone) and an agonist/antagonist (nalbuphine) in primate hemorrhagic shock: relationship to catecholamine release.
    McIntosh TK; Palter M; Grasberger R; Vezina R; Yeston NS; Egdahl RH
    Circ Shock; 1985; 17(4):313-25. PubMed ID: 4092345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opiate receptors and endorphins in the pathophysiology of hemorrhagic shock.
    Gurll NJ; Vargish T; Reynolds DG; Lechner RB
    Surgery; 1981 Mar; 89(3):364-9. PubMed ID: 6258256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of specific opioid-receptor antagonist naloxone on rats with hereditary hypothalamic diabetes insipidus (Brattleboro strain) during acute hemorrhagic shock.
    Machuganska A
    Acta Physiol Pharmacol Bulg; 1986; 12(1):62-9. PubMed ID: 3019080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
    Bitterman H; Yanagisawa A; Lefer AM
    Circ Shock; 1986; 20(1):1-11. PubMed ID: 2945667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
    Bitterman H; Smith BA; Lefer AM
    Circ Shock; 1988 Mar; 24(3):159-68. PubMed ID: 3383353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The mechanism of the action of opiate receptor antagonists in acute shock-induced blood loss].
    Sherman DM; Lafarenko VA
    Eksp Klin Farmakol; 1998; 61(1):25-9. PubMed ID: 9575407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T; Zukin RS
    Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effect of anisodamine in hemorrhagic shock.
    Su J; Hock CE; Lefer AM
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):360-5. PubMed ID: 6728045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the mouse vas deferens to determine mu, delta, and kappa receptor affinities of opioid antagonists.
    Cohen ML; Mendelsohn LG; Mitch CH; Zimmerman DM
    Receptor; 1994; 4(1):43-53. PubMed ID: 8038706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.